ETON - Eton Pharmaceuticals GAAP EPS of $0.04 misses by $0.01 revenue of $6.09M misses by $1.47M March, 16 2022 04:06 PM Eton Pharmaceutcials Inc. Eton Pharmaceuticals press release (NASDAQ:ETON): Q4 GAAP EPS of $0.04 misses by $0.01. Revenue of $6.09M (+7512.5% Y/Y) misses by $1.47M. Shares +1.78%. For further details see: Eton Pharmaceuticals GAAP EPS of $0.04 misses by $0.01, revenue of $6.09M misses by $1.47M